Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
16398 studies found for:    ( NOT NOTEXT ) [FIRST-RECEIVED-RESULTS-DATE]
Show Display Options
Rank Status Study
1 Completed
Has Results
Sorafenib and Bortezomib Treatment for Relapsed or Refractory Multiple Myeloma Patients
Condition: Multiple Myeloma
Interventions: Drug: Bortezomib;   Drug: Sorafenib
2 Completed
Has Results
n-3 Polyunsaturated Fatty Acids (PUFAs) in the Prevention of Atrial Fibrillation
Condition: Atrial Fibrillation
Interventions: Drug: n-3 PUFAs;   Drug: Placebo;   Drug: RASS inhibitors and/or RAS blockers;   Drug: Amiodarone
3 Completed
Has Results
Methylphenidate in Treating Patients With Fatigue Caused by Cancer
Conditions: Fatigue;   Unspecified Adult Solid Tumor, Protocol Specific
Interventions: Drug: methylphenidate hydrochloride;   Other: placebo
4 Completed
Has Results
A Randomized, Double-Blind Comparison of Placebo and Atomoxetine Hydrochloride Given Once a Day in Adults With Attention-Deficit/Hyperactivity Disorder (ADHD)
Condition: Attention Deficit Hyperactivity Disorder
Interventions: Drug: Atomoxetine Hydrochloride;   Drug: Placebo
5 Completed
Has Results
A Dose Range Finding Study to Evaluate the Efficacy and Safety of AZD9668 Administered Orally at Three Dose Levels to Patients With Chronic Obstructive Pulmonary Disease (COPD) on Treatment With Tiotropium
Condition: Chronic Obstructive Pulmonary Disease
Interventions: Drug: AZD9668;   Drug: AZD9668 Placebo
6 Completed
Has Results
An Efficacy Study of Combination of Tramadol and Acetaminophen Tablets in the Treatment of Participants With Fibromyalgia Pain
Conditions: Pain;   Fibromyalgia
Interventions: Drug: Tramadol hydrochloride;   Drug: Acetaminophen
7 Completed
Has Results
Memantine Treatment of Compulsive Buying
Condition: Compulsive Buying
Intervention: Drug: Memantine
8 Completed
Has Results
15 mg Mirtazapine Orally Disintegrating Tablets, Fasting
Condition: Healthy
Interventions: Drug: Mirtazapine 15 mg (Orally Disintegrating) Tablets;   Drug: REMERON SolTab® 15 mg Orally Disintegrating Tablets
9 Completed
Has Results
Losartan 100 mg Tablet in Healthy Subjects Under Non-Fasting Conditions
Condition: Healthy
Interventions: Drug: Losartan;   Drug: Cozaar®
10 Completed
Has Results
The Effect of Nebivolol in Hypertensive Patients With Coronary Artery Disease
Conditions: Hypertension;   Coronary Artery Disease
Interventions: Drug: Nebivolol;   Drug: Carvedilol
11 Active, not recruiting
Has Results
Therapy for Pediatric Relapsed or Refractory Acute Lymphoblastic Leukemia
Conditions: Acute Lymphoblastic Leukemia;   Lymphoma, Lymphoblastic
Interventions: Drug: Etoposide, cytarabine, vincristine, dexamethasone;   Drug: methotrexate, teniposide, PEG-asparaginase;   Drug: mitoxantrone, cyclophosphamide, mercaptopurine, vinblastine;   Drug: L-asparaginase, erwinia asparaginase;   Procedure: chemotherapy, intrathecal chemotherapy, steroid therapy;   Procedure: Hematopoietic Stem Cell Transplant;   Procedure: Natural Killer (NK) Cell Transplant
12 Completed
Has Results
TRADE-Testosterone Replacement and Dutasteride Effectiveness
Conditions: Hypogonadism;   Benign Prostatic Hyperplasia
Interventions: Drug: Dutasteride;   Drug: Testosterone gel;   Drug: Placebo dutasteride
13 Completed
Has Results
Cefadroxil 500 mg Capsules Under Fasting Conditions
Condition: Healthy
Interventions: Drug: Cefadroxil 500 mg Capsules;   Drug: DURICEF®  capsules 500 mg
14 Completed
Has Results
MK-2206 and AZD6244 in Patients With Advanced Colorectal Carcinoma
Condition: Colorectal Neoplasms
Intervention: Drug: MK-2206 + AZD6244
15 Completed
Has Results
Erlotinib Plus Docetaxel in Treating Patients With Stage IV or Recurrent Breast Cancer
Condition: Breast Cancer
Interventions: Drug: docetaxel;   Drug: erlotinib hydrochloride
16 Completed
Has Results
A Study to Evaluate the Safety and Efficacy of Sitagliptin 100 mg in Participants With Type 2 Diabetes Mellitus Who Have Inadequate Glycemic Control (MK-0431-229)
Condition: Type 2 Diabetes Mellitus
Interventions: Drug: Sitagliptin phosphate;   Drug: Comparator: placebo to pioglitazone;   Drug: Comparator: placebo to Sitagliptin;   Drug: Comparator: pioglitazone;   Drug: Glimepiride or gliclazide;   Drug: Metformin;   Drug: Pioglitazone rescue therapy
17 Completed
Has Results
Toronto Thromboprophylaxis Patient Safety Initiative
Condition: Venous Thromboembolism
Intervention: Other: Knowledge Translation (KT) toolkit
18 Completed
Has Results
European Active Surveillance Study for Intrauterine Devices
Condition: Uterine Perforation
Intervention:
19 Terminated
Has Results
Study of Temozolomide to Treat Newly Diagnosed Brain Metastases
Condition: Brain Metastases
Intervention: Drug: Temozolomide
20 Completed
Has Results
Open Label Safety And Efficacy Study Of Pregabalin In Subjects With Nerve Pain Asociated With Human Immunodeficiency Virus (HIV) Neuropathy
Conditions: Peripheral Neuropathy;   HIV Infections
Intervention: Drug: pregabalin

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Indicates status has not been verified in more than two years